{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:06:47Z","timestamp":1794560807139,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03858-y","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:43:52Z","timestamp":1783496632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DAS28-ESR may underestimate disease activity in rheumatoid arthritis patients with nonalcoholic fatty liver disease: a retrospective cohort study"],"prefix":"10.1186","volume":"28","author":[{"given":"Yutaka","family":"Shinkawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Fukumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mori","family":"Masato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Sato-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Umehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"1","key":"3858_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"issue":"1","key":"3858_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"11","key":"3858_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56(11):951\u201363. https:\/\/doi.org\/10.1007\/s00535-021-01796-x.","journal-title":"J Gastroenterol"},{"issue":"17","key":"3858_CR4","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl AM, Dasarathy S, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385(17):1559\u201369. https:\/\/doi.org\/10.1056\/NEJMoa2029349.","journal-title":"N Engl J Med"},{"issue":"1","key":"3858_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","journal-title":"J Hepatol"},{"issue":"1","key":"3858_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology. 2005;42(1):44\u201352. https:\/\/doi.org\/10.1002\/hep.20734.","journal-title":"Hepatology"},{"issue":"10","key":"3858_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","volume":"143","author":"M Hamaguchi","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143(10):722\u20138. https:\/\/doi.org\/10.7326\/0003-4819-143-10-200511150-00009.","journal-title":"Ann Intern Med"},{"issue":"9746","key":"3858_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094\u2013108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4.","journal-title":"Lancet"},{"key":"3858_CR9","doi-asserted-by":"publisher","first-page":"997270","DOI":"10.3389\/fimmu.2022.997270","volume":"13","author":"N Barbarroja","year":"2022","unstructured":"Barbarroja N, Ruiz-Ponce M, Cuesta-L\u00f3pez L, P\u00e9rez-S\u00e1nchez C, L\u00f3pez-Pedrera C, Arias-de la Rosa I, et al. Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk. Front Immunol. 2022;13:997270. https:\/\/doi.org\/10.3389\/fimmu.2022.997270.","journal-title":"Front Immunol"},{"issue":"11","key":"3858_CR10","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1016\/j.cgh.2023.02.021","volume":"21","author":"M Zamani","year":"2023","unstructured":"Zamani M, Alizadeh-Tabari S, Chitkara P, Singh S, Loomba R. Prevalence of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21(11):2880\u2013e28921. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.021.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3858_CR11","doi-asserted-by":"publisher","first-page":"rkaa020","DOI":"10.1093\/rap\/rkaa020","volume":"4","author":"S Mori","year":"2020","unstructured":"Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y, et al. Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: A longitudinal cohort study. Rheumatol Adv Pract. 2020;4(1):rkaa020. https:\/\/doi.org\/10.1093\/rap\/rkaa020.","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"3858_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324. https:\/\/doi.org\/10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3858_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381. https:\/\/doi.org\/10.1002\/art.27584.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3858_CR14","doi-asserted-by":"publisher","first-page":"e0318047","DOI":"10.1371\/journal.pone.0318047","volume":"20","author":"R Naito","year":"2025","unstructured":"Naito R, Taniguchi M, Onizawa H, Nakajima T, McCracken K, Mori M, et al. Upper extremity joint tenderness as a practical indicator for assessing presenteeism in rheumatoid arthritis patients: A cross-sectional observational study. PLoS ONE. 2025;20(1):e0318047. https:\/\/doi.org\/10.1371\/journal.pone.0318047.","journal-title":"PLoS ONE"},{"issue":"8","key":"3858_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","volume":"140","author":"O Steinbrocker","year":"1949","unstructured":"Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140(8):659\u201362.","journal-title":"J Am Med Assoc"},{"issue":"3","key":"3858_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007;66(3):407\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3858_CR17","first-page":"3719","volume":"54","author":"R Landew\u00e9","year":"2006","unstructured":"Landew\u00e9 R, van der Heijde D, van der Linden S, Boers M. Twenty-eight-joint counts invalidate the DAS28 remission definition but not the DAS28 low disease activity state: A comparison between the DAS28 and the original DAS remission definition. Arthritis Rheum. 2006;54(12):3719\u201324.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3858_CR18","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/ar3896","volume":"14","author":"B Zhang","year":"2012","unstructured":"Zhang B, Combe B, Rincheval N, Felson DT. Validation of ACR\/EULAR definition of remission in rheumatoid arthritis from RA practice: The ESPOIR cohort. Arthritis Res Ther. 2012;14(3):R156. https:\/\/doi.org\/10.1186\/ar3896.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3858_CR19","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/art.21235","volume":"52","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states. Arthritis Rheum. 2005;52(9):2625\u201336.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3858_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/rheumatology\/keu395","volume":"54","author":"T Sugihara","year":"2015","unstructured":"Sugihara T, Ishizaki T, Hosoya T, Iga S, Yokoyama W, Hirano F, Miyasaka N, Harigai M. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: A prospective cohort study (CRANE). Rheumatology (Oxford). 2015;54(5):798\u2013807. https:\/\/doi.org\/10.1093\/rheumatology\/keu395.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3858_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","volume":"71","author":"W Ogawa","year":"2024","unstructured":"Ogawa W, Ito C, Kitahara A, et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J. 2024;71(3):223\u201331. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0593.","journal-title":"Endocr J"},{"issue":"3","key":"3858_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"issue":"34","key":"3858_CR23","doi-asserted-by":"publisher","first-page":"e16816","DOI":"10.1097\/MD.0000000000016816","volume":"98","author":"V Alende-Castro","year":"2019","unstructured":"Alende-Castro V, Alonso-Sampedro M, Vazquez-Temprano N, Tu\u00f1ez C, Rey D, Garc\u00eda-Iglesias C, et al. Factors influencing erythrocyte sedimentation rate in adults: New evidence for an old test. Med (Baltim). 2019;98(34):e16816. https:\/\/doi.org\/10.1097\/MD.0000000000016816.","journal-title":"Med (Baltim)"},{"issue":"6","key":"3858_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2006.02.011.","journal-title":"J Hepatol"},{"issue":"12","key":"3858_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/acr.23229","volume":"69","author":"MD George","year":"2017","unstructured":"George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017;69(12):1789\u201398. https:\/\/doi.org\/10.1002\/acr.23229.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"3858_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11048","volume":"1","author":"EMA Eloseily","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB, Beukelman T, Ravelli A, Cron RQ. Ferritin to erythrocyte sedimentation rate ratio: Simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol. 2019;1(6):345\u20139. https:\/\/doi.org\/10.1002\/acr2.11048.","journal-title":"ACR Open Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03858-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03858-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03858-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:33:37Z","timestamp":1790818417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03858-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3858"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03858-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Nagahama City Hospital (approval number: H28-38). Patients gave verbal and written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.T. belongs to the department financially supported by two local governments in Japan (Nagahama City, Shiga and Toyooka City, Hyogo) and Asahi Kasei Pharma Corp. M.T. has received research grants and\/or speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Corp., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corp., Taisho Pharmaceutical Co., Ltd., Teijin Pharma, Ltd. A.M. has received research grants from Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Mitsubishi Tanabe Pharma Corp, and has received speaker fees from Astellas Pharma Inc., Bristol Myers Squibb Company., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"177"}}